$GeoVax Labs (GOVX.US)$Geovax Labs (NASDAQ:GOVX) reported quarterly losses of $(0.91) per share which beat the analyst consensus estimate of $(1.48) by 38.51 percent. The company reported quarterly sales of $2.789 million which beat the analyst consensus estimate of $918.750 thousand by 203.56 percent.
MrSuperStonk
:
in your dreams... this will have to go trough a wall of sells at .19 and then maybe hit .30. Corporations and regail dont sell. The only one selling right now are short sellers
$Tonix Pharmaceuticals (TNXP.US)$On November 12, 2024, Tonix Pharmaceuticals Holding Corp. reported its financial results for the third quarter ending September 30, 2024. The company, based in Chatham, New Jersey, announced a net product revenue of approximately $2.8 million, with net sales from Zembrace SymTouch and Tosymra, acquired from Upsher-Smith Laboratories, LLC. Research and development expenses decreased to $9.1 million from $21.0 million in the same period in 2023, reflecting a...
MrSuperStonk : i thinks its normal. will probably run tomorrow
102074066 : Bullish to bearish.